AB
BHVN icon

Amalgamated Bank’s Biohaven BHVN Stock Holding History

Amalgamated Bank’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,946
Closed -$33K – 1770
2025
Q4 		$33K Buy
2,946
+7
+0.2% +$87 ﹤0.01% 1940
2025
Q3 		$44K Hold
2,939
– – ﹤0.01% 1878
2025
Q2 		$41K Hold
2,939
– – ﹤0.01% 1875
2025
Q1 		$71K Buy
2,939
+10
+0.3% +$353 ﹤0.01% 1734
2024
Q4 		$109K Buy
2,929
+527
+22% +$24.6K ﹤0.01% 1688
2024
Q3 		$120K Hold
2,402
– – ﹤0.01% 1679
2024
Q2 		$83K Buy
2,402
+68
+3% +$2.69K ﹤0.01% 1756
2024
Q1 		$128K Sell
2,334
-3,787
-62% -$188K ﹤0.01% 1682
2023
Q4 		$262K Buy
6,121
+195
+3% +$6.06K ﹤0.01% 1710
2023
Q3 		$154K Hold
5,926
– – ﹤0.01% 1867
2023
Q2 		$142K Sell
5,926
-2,147
-27% -$37K ﹤0.01% 1942
2023
Q1 		$110K Sell
8,073
-1,590
-16% -$25.3K ﹤0.01% 2018
2022
Q4 		$134K Buy
+9,663
New +$136K ﹤0.01% 2014

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amalgamated Bank's BHVN Position: Q1 2026 in Review

Amalgamated Bank sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 2,946 shares — an estimated $33K sold.

Amalgamated Bank first reported a position in BHVN in Q4 2022 and held it in 13 quarters. The position peaked at $262K in Q4 2023. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Amalgamated Bank reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,946 Biohaven shares in Q1 2026, an estimated $33K.
  • Amalgamated Bank first reported a position in Biohaven in Q4 2022 and held it in 13 quarters.
  • Amalgamated Bank's Biohaven position peaked at $262K in Q4 2023.
  • 276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.